✦ LIBER ✦

Receptor Heterodimerization: A New Mechanism for Platelet-Derived Growth Factor Induced Resistance to Anti-Epidermal Growth Factor Receptor Therapy for Bladder Cancer

✍ Scribed by Black, Peter C.; Brown, Gordon A.; Dinney, Colin P.; Kassouf, Wassim; Inamoto, Teruo; Arora, Ameeta; Gallagher, David; Munsell, Mark F.; Bar-Eli, Menashe; McConkey, David J.; Adam, Liana

Book ID: 123490283
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 852 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.09.082

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Receptor Heterodimerization: Essential M

Receptor Heterodimerization: Essential Mechanism for Platelet-Derived Growth Factor-Induced Epidermal Growth Factor Receptor Transactivation

✍ Saito, Y.; Haendeler, J.; Hojo, Y.; Yamamoto, K.; Berk, B. C. 📂 Article 📅 2001 🏛 American Society for Microbiology 🌐 English ⚖ 329 KB

Monoclonal antibodies to target epiderma

Monoclonal antibodies to target epidermal growth factor receptor–positive tumors : A new paradigm for cancer therapy

✍ Roy S. Herbst; Dong M. Shin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

688 Epidermal growth factor receptor (EG

688 Epidermal growth factor receptor (EGFR) status predicts outcome following external beam radiation therapy (EBRT) for muscle-invasive bladder cancer

✍ A. Colquhoun; S. Sundar; P. Rajjayabun; L. Griffiths; P. Symonds; K. Mellon 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Tyrosine kinase inhibitors of the epider

Tyrosine kinase inhibitors of the epidermal growth factor receptor as adjuncts to systemic chemotherapy for muscle-invasive bladder cancer

✍ Lynsey A McHugh; T.R.Leyshon Griffiths; Marina Kriajevska; R.Paul Symonds; J.Kil 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 155 KB

96: Analysis of aberrant epidermal growt

96: Analysis of aberrant epidermal growth factor receptor (EGFR) pathway signaling in pancreatic cancer patients: Implications for anti-EGFR therapy

✍ C.D. Tzeng; A. Frolov; J.H. Howard; S.M. Vickers; D.J. Buchsbaum; M.J. Heslin; J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 104 KB

CRKL amplification is rare as a mechanis

CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation

✍ Suda, Kenichi; Mizuuchi, Hiroshi; Murakami, Isao; Uramoto, Hidetaka; Tanaka, Fum 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 157 KB